NCT02837471View on ClinicalTrials.gov

Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Cardiovascular Disease
Interventions
DEVICE

PiezoRx medical grade pedometer

"Participants will be asked to freely use the PiezoRx medical grade pedometer for 12 weeks.~Participants have access to a personal account created online and can record the daily steps count and physical activity.~Participants will receive the standard care by the FrancoForme Cardiovascular rehabilitation and prevention program"

Trial Locations (2)

K1Y 4W7

University of Ottawa Heart Insititue, Ottawa

K1Y4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

StepsCount Inc

UNKNOWN

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT02837471 - Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians | Biotech Hunter | Biotech Hunter